COST-EFFECTIVENESS SIMULATION ANALYSIS OF TENOFOVIR DISOPROXIL FUMARATE (TDF), LAMIVUDINE (LAM), ADEFOVIR DIPIVOXIL (ADV) AND ENTECAVIR (ETV) IN HBEAG NEGATIVE (-) PATIENTS WITH CHRONIC HEPATITIS B (CHB) IN THE USA

被引:0
作者
Deniz, H. B. [1 ]
Everhard, Francois [2 ]
机构
[1] United BioSource Corp, Hlth Econ, Concord, MA USA
[2] Gilead Sci Inc, Commercial Strat Grp, Foster City, CA 94404 USA
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
976
引用
收藏
页码:744A / 744A
页数:1
相关论文
empty
未找到相关数据